Response to Hermosa-Gelbard et al., "Switching from deuruxolitinib to baricitinib in alopecia areata: A real-world cohort of 36 patients"

Paz M, Chen LC, Ezzat RZ, Kreytak C, Hunt J, Senna MM. Response to Hermosa-Gelbard et al., "Switching from deuruxolitinib to baricitinib in alopecia areata: A real-world cohort of 36 patients". J Am Acad Dermatol. Published online 2026.